KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,783 | -40.0% | 117 | -23.0% | 0.00% | – |
Q2 2023 | $32,961 | +124.0% | 152 | +87.7% | 0.00% | – |
Q1 2023 | $14,713 | -91.9% | 81 | -91.3% | 0.00% | – |
Q4 2022 | $182,746 | +530.2% | 930 | +594.0% | 0.00% | – |
Q3 2022 | $29,000 | +222.2% | 134 | +100.0% | 0.00% | – |
Q2 2022 | $9,000 | -18.2% | 67 | -23.9% | 0.00% | – |
Q1 2022 | $11,000 | +10.0% | 88 | +17.3% | 0.00% | – |
Q4 2021 | $10,000 | +25.0% | 75 | +13.6% | 0.00% | – |
Q3 2021 | $8,000 | +300.0% | 66 | +230.0% | 0.00% | – |
Q2 2021 | $2,000 | +100.0% | 20 | +185.7% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 7 | -22.2% | 0.00% | – |
Q1 2020 | $1,000 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |